Q4 Revenue: $138 million, 4% above guidance. Full Year Revenue: $570 million, 20% year-on-year growth. Top 20 Clients Growth: 23% in fiscal 2025. Q4 Adjusted EBITDA Margin: 50%, $70 million, 10% above guidance. Q4 Free Cash Flow: $97 million, up 56% year-on-year. Full Year Adjusted EBITDA: $314 million, 36% growth. Full Year Adjusted EBITDA Margin: 55%, up from 48% prior year. Full Year Free Cash Flow: $267 million, 50% increase year-on-year. Net Revenue Retention Rate: 119% overall, 123% for top 20 customers. Customers with $500K+ Revenue: 116 customers, 17% increase from last year. Q4 Non-GAAP Gross Margin: 91%, flat year-over-year. Full Year Non-GAAP Gross Margin: 92%, up from 91% last year. Cash and Equivalents: $916 million at year-end. Share Repurchase: $26.8 million in Q4, $116.2 million for the full year. Q1 2026 Revenue Guidance: $139 million to $140 million, 10% growth at midpoint. Q1 2026 Adjusted EBITDA Guidance: $71 million to $72 million, 51% margin. Full Year 2026 Revenue Guidance: $619 million to $631 million, 10% growth at midpoint. Full Year 2026 Adjusted EBITDA Guidance: $333 million to $345 million, 54% margin.

Warning! GuruFocus has detected 3 Warning Signs with RNXT.

Release Date: May 15, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Doximity Inc (NYSE:DOCS) reported $138 million in revenue for Q4 2025, exceeding the high end of their guidance by 4%. The company achieved a 20% year-over-year revenue growth for the full fiscal year, reaching $570 million. Adjusted EBITDA margin for Q4 was 50%, surpassing guidance by 10%, and for the full year, it was 55%, up from 48% the previous year. Unique active users across all timeframes hit new highs, with significant growth in their news feed and AI tools. Doximity's integrated offerings and AI-powered tools are gaining traction, leading to larger deal sizes and improved client engagement.

Negative Points

Despite strong performance, Doximity Inc (NYSE:DOCS) is cautious about potential macroeconomic uncertainties affecting future growth. The company anticipates a tougher year-over-year comparison for fiscal 2026 due to the strategic shift in program launches. There is a reliance on a small number of large clients, with the top 20 customers contributing significantly to revenue growth. The market growth rate for the pharma HCP digital market is expected to be on the lower end of the 5% to 7% range. Doximity Inc (NYSE:DOCS) is still in the early stages of AI investment, and the long-term impact on margins and efficiency remains uncertain.

Story Continues

Q & A Highlights

Q: How are your customer conversations regarding their willingness to spend this year, given the macroeconomic volatility? A: Jeffrey Tangney, CEO, stated that despite the macroeconomic uncertainty, there has been no sign of a market slowdown. Clients are excited about AI, and those using AI optimization are growing at double the rate of others. The Pharma Advisory Board showed cautious optimism, with a focus on AI and ROI insights from the client portal.

Q: Can you provide insights on the AI investments planned for fiscal year '26 and their expected payback period? A: Anna Bryson, CFO, mentioned that while it's early to determine the exact payback period, AI investments have already contributed to margin expansion. The company is scaling without significant headcount increases, indicating AI's effectiveness in driving efficiency.

Q: How are you balancing growth across different product lines like physician recruitment and point-of-care formulary for FY26? A: Anna Bryson highlighted that the pharma business, particularly formulary and point-of-care products, will continue to lead growth. The health systems business has shown marginal improvement, but guidance remains cautious due to potential macro impacts.

Q: What are the expectations for new drug approvals and their impact on revenue outlook for FY26? A: Anna Bryson noted that while there is policy uncertainty, the science behind new therapies is promising. The company is monitoring the situation, but expects to maintain a strong competitive position due to high ROI and strategic client relationships.

Q: How is the client portal influencing upsells and client engagement? A: Jeffrey Tangney explained that the client portal provides real-time ROI insights, enhancing transparency and strategic partnerships. While direct purchases aren't yet possible through the portal, it facilitates upsell motions and improves revenue visibility.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

View Comments